Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21810686 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR
Conditions: Skin Diseases;   Carcinoma, Squamous Cell
Intervention: Drug: cetuximab

Indicates status has not been verified in more than two years